Furthermore, high SAV1 expression conferred better overall survival (OS) in non-small cell lung cancer (NSCLC) comprising lung adenocarcinoma (LUAD) and lung squamous carcinoma (LUSC) (Fig. 2D). Here, SAV1 is linked to non-small cell lung carcinoma.